Logo image of IMP.CA

INTERMAP TECHNOLOGIES CORP (IMP.CA) Stock Fundamental Analysis

Canada - TSX:IMP - CA4589774021 - Common Stock

3.23 CAD
-0.22 (-6.38%)
Last: 9/16/2025, 7:00:00 PM
Fundamental Rating

4

Overall IMP gets a fundamental rating of 4 out of 10. We evaluated IMP against 64 industry peers in the Software industry. IMP may be in some trouble as it scores bad on both profitability and health. IMP is not priced too expensively while it is growing strongly. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

IMP had positive earnings in the past year.
IMP had a negative operating cash flow in the past year.
In multiple years IMP reported negative net income over the last 5 years.
IMP had a negative operating cash flow in each of the past 5 years.
IMP.CA Yearly Net Income VS EBIT VS OCF VS FCFIMP.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

IMP has a Return On Assets of 4.78%. This is in the better half of the industry: IMP outperforms 78.13% of its industry peers.
IMP has a Return On Equity of 8.41%. This is in the better half of the industry: IMP outperforms 75.00% of its industry peers.
The Return On Invested Capital of IMP (6.59%) is better than 70.31% of its industry peers.
Industry RankSector Rank
ROA 4.78%
ROE 8.41%
ROIC 6.59%
ROA(3y)-48.26%
ROA(5y)31.78%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IMP.CA Yearly ROA, ROE, ROICIMP.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

1.3 Margins

IMP has a Profit Margin of 3.36%. This is in the better half of the industry: IMP outperforms 65.63% of its industry peers.
IMP has a better Operating Margin (3.93%) than 67.19% of its industry peers.
IMP's Gross Margin of 10.40% is on the low side compared to the rest of the industry. IMP is outperformed by 68.75% of its industry peers.
Industry RankSector Rank
OM 3.93%
PM (TTM) 3.36%
GM 10.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IMP.CA Yearly Profit, Operating, Gross MarginsIMP.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IMP is destroying value.
IMP has more shares outstanding than it did 1 year ago.
IMP has more shares outstanding than it did 5 years ago.
IMP has a better debt/assets ratio than last year.
IMP.CA Yearly Shares OutstandingIMP.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
IMP.CA Yearly Total Debt VS Total AssetsIMP.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

Based on the Altman-Z score of -8.07, we must say that IMP is in the distress zone and has some risk of bankruptcy.
IMP has a Altman-Z score of -8.07. This is in the lower half of the industry: IMP underperforms 75.00% of its industry peers.
IMP has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.06, IMP is in the better half of the industry, outperforming 65.63% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z -8.07
ROIC/WACC0.6
WACC10.99%
IMP.CA Yearly LT Debt VS Equity VS FCFIMP.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

2.3 Liquidity

IMP has a Current Ratio of 1.71. This is a normal value and indicates that IMP is financially healthy and should not expect problems in meeting its short term obligations.
IMP's Current ratio of 1.71 is fine compared to the rest of the industry. IMP outperforms 62.50% of its industry peers.
IMP has a Quick Ratio of 1.71. This is a normal value and indicates that IMP is financially healthy and should not expect problems in meeting its short term obligations.
IMP has a better Quick ratio (1.71) than 62.50% of its industry peers.
Industry RankSector Rank
Current Ratio 1.71
Quick Ratio 1.71
IMP.CA Yearly Current Assets VS Current LiabilitesIMP.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 121.47% over the past year.
IMP shows a strong growth in Revenue. In the last year, the Revenue has grown by 149.84%.
IMP shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.91% yearly.
EPS 1Y (TTM)121.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-196.5%
Revenue 1Y (TTM)149.84%
Revenue growth 3Y44.88%
Revenue growth 5Y11.91%
Sales Q2Q%-14.99%

3.2 Future

IMP is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 101.65% yearly.
IMP is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 48.61% yearly.
EPS Next Y100%
EPS Next 2Y112.13%
EPS Next 3Y101.65%
EPS Next 5YN/A
Revenue Next Year85.89%
Revenue Next 2Y83.11%
Revenue Next 3Y64.46%
Revenue Next 5Y48.61%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
IMP.CA Yearly Revenue VS EstimatesIMP.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20M 40M 60M 80M
IMP.CA Yearly EPS VS EstimatesIMP.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0.1 0.2 0.3 0.4

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 323.00, the valuation of IMP can be described as expensive.
The rest of the industry has a similar Price/Earnings ratio as IMP.
The average S&P500 Price/Earnings ratio is at 27.20. IMP is valued rather expensively when compared to this.
Based on the Price/Forward Earnings ratio of 10.34, the valuation of IMP can be described as reasonable.
Based on the Price/Forward Earnings ratio, IMP is valued cheaper than 87.50% of the companies in the same industry.
IMP is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.71, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 323
Fwd PE 10.34
IMP.CA Price Earnings VS Forward Price EarningsIMP.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IMP is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 65.74
IMP.CA Per share dataIMP.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3 0.4

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates IMP does not grow enough to justify the current Price/Earnings ratio.
IMP's earnings are expected to grow with 101.65% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.23
PEG (5Y)N/A
EPS Next 2Y112.13%
EPS Next 3Y101.65%

0

5. Dividend

5.1 Amount

No dividends for IMP!.
Industry RankSector Rank
Dividend Yield N/A

INTERMAP TECHNOLOGIES CORP

TSX:IMP (9/16/2025, 7:00:00 PM)

3.23

-0.22 (-6.38%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-14 2025-08-14/amc
Earnings (Next)11-12 2025-11-12
Inst Owners0.12%
Inst Owner ChangeN/A
Ins Owners14.73%
Ins Owner ChangeN/A
Market Cap194.48M
Analysts80
Price Target5.36 (65.94%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-148.51%
Min EPS beat(2)-298.02%
Max EPS beat(2)0.99%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-35.11%
Min Revenue beat(2)-39.72%
Max Revenue beat(2)-30.51%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)16.67%
PT rev (3m)31.25%
EPS NQ rev (1m)-33.33%
EPS NQ rev (3m)N/A
EPS NY rev (1m)42.86%
EPS NY rev (3m)42.86%
Revenue NQ rev (1m)-33.33%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-2.97%
Revenue NY rev (3m)-5.02%
Valuation
Industry RankSector Rank
PE 323
Fwd PE 10.34
P/S 7.18
P/FCF N/A
P/OCF N/A
P/B 17.98
P/tB 19.95
EV/EBITDA 65.74
EPS(TTM)0.01
EY0.31%
EPS(NY)0.31
Fwd EY9.67%
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0.45
BVpS0.18
TBVpS0.16
PEG (NY)3.23
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.78%
ROE 8.41%
ROCE 9.16%
ROIC 6.59%
ROICexc 84.18%
ROICexgc N/A
OM 3.93%
PM (TTM) 3.36%
GM 10.4%
FCFM N/A
ROA(3y)-48.26%
ROA(5y)31.78%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover1.42
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA 0.25
Cap/Depr 103.06%
Cap/Sales 6.66%
Interest Coverage 7.37
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.71
Quick Ratio 1.71
Altman-Z -8.07
F-Score6
WACC10.99%
ROIC/WACC0.6
Cap/Depr(3y)85.1%
Cap/Depr(5y)73.43%
Cap/Sales(3y)7.7%
Cap/Sales(5y)11.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)121.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-196.5%
EPS Next Y100%
EPS Next 2Y112.13%
EPS Next 3Y101.65%
EPS Next 5YN/A
Revenue 1Y (TTM)149.84%
Revenue growth 3Y44.88%
Revenue growth 5Y11.91%
Sales Q2Q%-14.99%
Revenue Next Year85.89%
Revenue Next 2Y83.11%
Revenue Next 3Y64.46%
Revenue Next 5Y48.61%
EBIT growth 1Y143.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year193.33%
EBIT Next 3YN/A
EBIT Next 5Y82.06%
FCF growth 1Y-332.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-396.77%
OCF growth 3YN/A
OCF growth 5YN/A